#smallmolecules

We are at the forefront of bioanalytical innovation, offering a wide range of services, seamlessly supporting both small and large molecule drug development. For small molecules: Fit-for-purpose bioanalytical methods are developed for discovery studies. GLP-compliant bioanalysis using fully validated bioanalytical methods are performed for studies conducted for regulatory submission. Our team has extensive expertise in developing sensitive methods on LC-MS/MS platforms, including analysis of multi-analytes, metabolites, pro-drugs, and photo/temperature sensitive and ex-vivo unstable compounds. Analytical methods for new chemical entities are routinely established and validated. For large molecules: our team has immense experience in developing and validating sensitive and specific analytical/immunogenicity methods for different modalities such as peptides, enzymes, monoclonal antibodies, vaccines, and gene therapy products. These immunoanalytical methods are designed and optimized specifically to the requirements of your product. We are committed to delivering the highest quality data that meets stringent regulatory requirements. We operate under robust quality systems and adhere to global regulatory guidelines, ensuring data integrity and reliability for your programs. Contact us for your specific requirement – [email protected]

From early discovery to clinical trials our biomarker bioanalysis services help advance your R&D. Our team has expertise to work on small and large molecules - develop and validate methods to analyze biomarkers in preclinical and clinical samples. Connect with us for your specific requirement 📧 [email protected]

We understand the critical role that comprehensive safety evaluation plays in drug development. Our team of experts along with advanced technologies and specialized equipment enables us to conduct precise and reliable studies. We are committed to providing exceptional services to our clients. Partner with us for comprehensive safety assessment services that keep your projects on track and risk-free. 🤝 To know more, click on the link 👉 https://lnkd.in/g6eBPfa2

Eurofins Advinus offers comprehensive safety assessment studies ranging from efficacy studies in multiple therapeutic areas, pharmacokinetics, and metabolism studies, single-dose, repeated dose toxicology, genetic toxicology, safety pharmacology, development and reproductive toxicology, chronic toxicology (3 months to 2 years), carcinogenicity and in vitro studies.

We provide comprehensive services to help with drug substance development and manufacturing. With our experience and proven track record of successful partnerships, we offer global quality at competitive price with optimal time and resource management. Our team has expertise in developing novel, safe, efficient and environmentally friendly routes for synthesis of complex molecules. Our capabilities include route scouting, fit-for-purpose process development, process safety evaluation, analytical method development and validation, stability studies and scale-up of drug substances for toxicity assessment and clinical studies. For more details 👉 https://lnkd.in/d58ACeEH

As you are aware our state-of-the-art facility in Hyderabad, India is dedicated to Drug Discovery and Development Services. We at Eurofins Advinus are committed to advancing research and making a meaningful impact on healthcare worldwide. From target identification and lead optimization to preclinical development, our Hyderabad facility offers a comprehensive range of integrated drug discovery services. We provide end-to-end solutions that enable our partners to accelerate their research. Our multidisciplinary teams work together seamlessly, ensuring that we deliver the best results for our partners. To connect with our team of experts, please reach out to [email protected] Looking forward to collaborating with you!

Looking forward to meeting you at the upcoming 17th WRIB conference. Our bioanalytical expert will be at the conference from June 19-23, 2023 in Orlando Disney Springs, Florida to discuss and share ideas in the field of bioanalytical sciences. Eurofins Advinus bioanalytical group specializes in quantitative LC-MS/MS method development, method validation and study sample analysis. Bioanalytical services are routinely provided for compounds in discovery, and in preclinical and clinical development. Fit-for-purpose bioanalytical methods are developed for discovery studies. GLP-compliant bioanalysis using fully validated methods developed are performed for studies conducted for regulatory submission. Our team has extensive expertise in developing sensitive methods for LC-MS/MS, including analysis of multi-analytes, metabolites, pro-drugs, and photo/temperature sensitive and ex-vivo instable compounds. To schedule a meeting, email us at [email protected]

Metabolite identification studies are crucial during drug discovery and development. These studies facilitate soft-spot identification and help to design compounds with favorable properties. They also help identify pharmacologically active and chemically reactive metabolites that may have potential toxicity or other liabilities. Eurofins Advinus provides metabolite identification studies at both, early discovery and preclinical development, stages. The team is highly experienced and has expertise in chemistry and biochemistry to support such investigations. The Eurofins Advinus Discovery Services team is here to help you understand the biotransformation pathways of small molecules and elucidate metabolite structures in various biological matrices by Metabolite Profiling. Our team has expertise in - 🔵 Metabolite Identification in sub-cellular fractions, hepatocytes, and in vivo samples 🔵 Cross-species comparison in metabolism 🔵 Tentative structure prediction using LCMS/MS 🔵 Reactive metabolite trapping using Glutathione 🔵 Assays conducted with radiolabeled and unlabeled compounds For more details, email us at [email protected] “It has been observed that fake employment offers are being made, via email and otherwise, by misusing Eurofins Advinus name. Please be informed that Eurofins Advinus does not require any payment or fees from prospective candidates and Eurofins Advinus does not send any recruitment email from generic email addresses other than email addresses ending with “advinus.com”. ”